Hims & Hers Health, a telehealth platform specializing in men’s and women’s health, has agreed to acquire Eucalyptus, a digital health company focused on chronic disease management, in a $1.15 billion transaction. The deal aims to expand Hims & Hers’ geographic footprint beyond its current operations in the U.S. and Canada, leveraging Eucalyptus’ expertise in scaling health technology solutions. This move signals aggressive growth ambitions for the company, which has seen rapid adoption of its direct-to-consumer (DTC) healthcare model since its 2019 launch.

The acquisition highlights the intensifying consolidation in the digital health sector, where companies are racing to integrate telemedicine, prescription services, and chronic care management. Eucalyptus, founded in 2020, has built a reputation for its data-driven approach to managing conditions like diabetes and hypertension, a niche that aligns with Hims & Hers’ diversification strategy. By absorbing Eucalyptus’ technology and clinical networks, Hims & Hers aims to strengthen its position as a one-stop platform for preventive and ongoing healthcare needs.

Analysts note the deal’s strategic significance: Hims & Hers has raised over $1.5 billion in funding since inception, reflecting investor confidence in its ability to disrupt traditional healthcare delivery. The addition of Eucalyptus’ assets, including its proprietary AI-driven patient engagement tools, could enhance the acquirer’s ability to personalize care and reduce no-show rates—a critical metric in telehealth. This aligns with broader industry trends toward value-based care models that prioritize patient outcomes over volume.

The transaction, expected to close by mid-2024, will be financed through a combination of cash and debt, though specific terms remain undisclosed. While Hims & Hers has not disclosed Eucalyptus’ employee count or patient base, industry estimates suggest the acquired company serves over 500,000 users annually. The deal underscores the growing appetite for tech-enabled healthcare solutions, particularly as reimbursement policies evolve to favor remote care delivery.